VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients
April 17, 2018 08:00 ET
|
VBI Vaccines, Inc.
Independent Data and Safety Monitoring Board (DSMB) unanimously recommends continuation of study without modificationLow-dose study arm: enrollment completeIntermediate-dose study arm: enrollment...
Profiling Brain Cancers for More Targeted Treatments
December 22, 2017 09:03 ET
|
The Jackson Laboratory
Farmington, Conn., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Roel Verhaak, Ph.D., is not beholden to the status quo. After all, his field, computational biology, didn’t exist, at least not formally, when he...
National Brain Tumor Society 2017 Scientific Summit Showcases Research & Treatment Development Opportunities in Neuro-Oncology Field
October 31, 2017 15:29 ET
|
National Brain Tumor Society
BOSTON, MA--(Marketwired - October 31, 2017) - National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, recently hosted its annual...
National Brain Tumor Society Announces Multitude of New Discoveries to Enable Potential Future Brain Tumor Treatments
June 27, 2017 12:05 ET
|
National Brain Tumor Society
BOSTON, MA--(Marketwired - June 27, 2017) - National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today, through its subsidiary Cure...
Clinical Data Presented at ASCO Demonstrate Significant Overall Survival Benefit in rGBM Patients Receiving VB-111 Compared with Historical Avastin® Meta-analysis Data
June 03, 2016 16:02 ET
|
VBL Therapeutics
VBL's Phase 2 study in recurrent glioblastoma (rGBM) met the primary endpoint of statistically-significant increase in median overall survival, with 59 weeks in patients treated with continuous...
Collaborations in Neurosurgery: MRI Interventions' ClearPoint System and Monteris Medical's NeuroBlate System Utilized Jointly to Enable Laser Ablation of Brain Tumor
June 23, 2014 08:00 ET
|
ClearPoint Neuro, Inc.
IRVINE, Calif. and MINNEAPOLIS, June 23, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) and Monteris Medical, Corp. jointly announced the utilization of their respective product...